Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/1380| Title: | Safety profile of methotrexate in patients with Rheumatoid arthritis |
| Authors: | REGNO:BG0119006 |
| Issue Date: | 2022 |
| Publisher: | KLE Academy of Higher Education and Research, Belagavi |
| Abstract: | Background: Methotrexate (MTX) is recommended as first-line therapy in patients with active RA as monotherapy or in combination with other disease-modifying anti-rheumatic drugs (DMARDs). Despite being considered a safe drug, some toxicities of MTX are inevitable and patients are stopping further treatment with MTX for the same. Objective: To evaluate the safety profile of Methotrexate in patients with Rheumatoid Arthritis (RA). |
| URI: | http://localhost:8080/xmlui/handle/123456789/1380 |
| Appears in Collections: | General Medicine MD |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| REG NO BG0119006.pdf | 3.7 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.